Literature DB >> 22280057

Tumor-cell co-culture induced alternative activation of macrophages is modulated by interferons in vitro.

Ulrike Carolin Müller-Quernheim1, Lars Potthast, Joachim Müller-Quernheim, Gernot Zissel.   

Abstract

Tumor-associated macrophages infiltrate tumors and facilitate tumor growth. Here, we analyzed M1 and M2 marker expression in the course of co-culture-driven macrophage differentiation and investigated the influence of interferons (IFNs) on this differentiation. To generate monocyte-derived macrophages (MDMs) 1×10⁶ monocytes of healthy volunteers were cultivated either with 25×10³ adherent A549/mL or in medium containing 50% A549 conditioned medium (CM) for 72 h in the presence or absence of IFN-α, β or γ, respectively. Supernatants were tested for CCL18 (M2 marker) and CXCL10 (M1 marker) by enzyme-linked immunosorbent assay. CCL18 and CXCL10 release by MDM is increased by the presence of A549 cells, but also when cultured in A549 CM. On stimulation with IFN-γ, we observe an increased release of the M1 marker CXCL10 and a decreased release of CCL18. Type I IFNs also increases CXCL10 release. Thus, A549 releases a soluble factor which enhances CCL18 production and M2 polarization, indicating that a localized specific cytokine milieu, as found in the environment of a tumor or in fibrotic lung tissue, favors alternative activation of macrophages. In the presence of IFN-γ, M2 differentiation is attenuated as shown by the decrease of the M2 chemokine CCL18 and by the increase of the M1 chemokine CXCL10. However, CXCL10 levels were also increased by the co-culture, which indicates a simultaneous classical activation (M1) or the formation of a M1/M2 hybrid.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22280057      PMCID: PMC3319930          DOI: 10.1089/jir.2011.0020

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  42 in total

1.  Expression and function of beta 2 integrins on alveolar macrophages from human and nonhuman primates.

Authors:  R K Albert; L J Embree; J E McFeely; D D Hickstein
Journal:  Am J Respir Cell Mol Biol       Date:  1992-08       Impact factor: 6.914

2.  A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-kappaB and enhanced IRF-3/STAT1 activation).

Authors:  Subhra K Biswas; Lisa Gangi; Saki Paul; Tiziana Schioppa; Alessandra Saccani; Marina Sironi; Barbara Bottazzi; Andrea Doni; Bronte Vincenzo; Fabio Pasqualini; Luca Vago; Manuela Nebuloni; Alberto Mantovani; Antonio Sica
Journal:  Blood       Date:  2005-11-03       Impact factor: 22.113

3.  CpG-A-induced monocyte IFN-gamma-inducible protein-10 production is regulated by plasmacytoid dendritic cell-derived IFN-alpha.

Authors:  Sue E Blackwell; Arthur M Krieg
Journal:  J Immunol       Date:  2003-04-15       Impact factor: 5.422

4.  Significance of alternatively activated macrophages in patients with intrahepatic cholangiocarcinoma.

Authors:  Horlad Hasita; Yoshihiro Komohara; Hirohisa Okabe; Toshiro Masuda; Koji Ohnishi; Xiao F Lei; Toru Beppu; Hideo Baba; Motohiro Takeya
Journal:  Cancer Sci       Date:  2010-05-12       Impact factor: 6.716

5.  The immunomodulating effect of interferon-gamma intravesical instillations in preventing bladder cancer recurrence.

Authors:  Aris Giannopoulos; Constantinos Constantinides; Eleftherios Fokaeas; Constantinos Stravodimos; Myrto Giannopoulou; Aspasia Kyroudi; Antonia Gounaris
Journal:  Clin Cancer Res       Date:  2003-11-15       Impact factor: 12.531

6.  Macrophages may promote cancer growth via a GM-CSF/HB-EGF paracrine loop that is enhanced by CXCL12.

Authors:  Antonella Rigo; Michele Gottardi; Alberto Zamò; Pierluigi Mauri; Massimiliano Bonifacio; Mauro Krampera; Ernesto Damiani; Giovanni Pizzolo; Fabrizio Vinante
Journal:  Mol Cancer       Date:  2010-10-14       Impact factor: 27.401

7.  GM-CSF- and M-CSF-dependent macrophage phenotypes display differential dependence on type I interferon signaling.

Authors:  Andrew J Fleetwood; Hang Dinh; Andrew D Cook; Paul J Hertzog; John A Hamilton
Journal:  J Leukoc Biol       Date:  2009-04-30       Impact factor: 4.962

Review 8.  Pegylated interferons: prospects for the use in the adjuvant and palliative therapy of metastatic melanoma.

Authors:  Katharina C Kaehler; Vernon K Sondak; Dirk Schadendorf; Axel Hauschild
Journal:  Eur J Cancer       Date:  2010-01       Impact factor: 9.162

Review 9.  Pulmonary fibrosis: cytokines in the balance.

Authors:  R K Coker; G J Laurent
Journal:  Eur Respir J       Date:  1998-06       Impact factor: 16.671

10.  CCL2, a product of mice early after systemic inflammatory response syndrome (SIRS), induces alternatively activated macrophages capable of impairing antibacterial resistance of SIRS mice.

Authors:  Yasuhiro Tsuda; Hitoshi Takahashi; Makiko Kobayashi; Toshiaki Hanafusa; David N Herndon; Fujio Suzuki
Journal:  J Leukoc Biol       Date:  2004-05-03       Impact factor: 4.962

View more
  8 in total

1.  Matrix stiffness and tumor-associated macrophages modulate epithelial to mesenchymal transition of human adenocarcinoma cells.

Authors:  Marta Alonso-Nocelo; Theresa M Raimondo; Kyle H Vining; Rafael López-López; Maria de la Fuente; David J Mooney
Journal:  Biofabrication       Date:  2018-03-28       Impact factor: 9.954

2.  Tumor Cells Modulate Macrophage Phenotype in a Novel In Vitro Co-Culture Model of the NSCLC Tumor Microenvironment.

Authors:  Josiah Voth Park; Raghav Chandra; Ling Cai; Debolina Ganguly; Huiyu Li; Jason E Toombs; Luc Girard; Rolf A Brekken; John D Minna
Journal:  J Thorac Oncol       Date:  2022-07-05       Impact factor: 20.121

Review 3.  Phosphoinositide 3-kinase/Akt and its related signaling pathways in the regulation of tumor-associated macrophages polarization.

Authors:  Depeng Yang; Lijun Yang; Jialing Cai; Huaxin Li; Zheng Xing; Ying Hou
Journal:  Mol Cell Biochem       Date:  2022-05-19       Impact factor: 3.842

4.  Tumor Presence Induces Global Immune Changes and Enhances Nanoparticle Clearance.

Authors:  Marc P Kai; Hailey E Brighton; Catherine A Fromen; Tammy W Shen; J Christopher Luft; Yancey E Luft; Amanda W Keeler; Gregory R Robbins; Jenny P Y Ting; William C Zamboni; James E Bear; Joseph M DeSimone
Journal:  ACS Nano       Date:  2015-12-02       Impact factor: 15.881

5.  Cytokine profiling of docetaxel-resistant castration-resistant prostate cancer.

Authors:  K L Mahon; H-M Lin; L Castillo; B Y Lee; M Lee-Ng; M D Chatfield; K Chiam; S N Breit; D A Brown; M P Molloy; G M Marx; N Pavlakis; M J Boyer; M R Stockler; R J Daly; S M Henshall; L G Horvath
Journal:  Br J Cancer       Date:  2015-03-31       Impact factor: 7.640

6.  CCL18 Expression Is Higher in a Glioblastoma Multiforme Tumor than in the Peritumoral Area and Causes the Migration of Tumor Cells Sensitized by Hypoxia.

Authors:  Szymon Grochans; Jan Korbecki; Donata Simińska; Wojciech Żwierełło; Sylwia Rzeszotek; Agnieszka Kolasa; Klaudyna Kojder; Maciej Tarnowski; Dariusz Chlubek; Irena Baranowska-Bosiacka
Journal:  Int J Mol Sci       Date:  2022-08-01       Impact factor: 6.208

Review 7.  CCL18 in the Progression of Cancer.

Authors:  Jan Korbecki; Mateusz Olbromski; Piotr Dzięgiel
Journal:  Int J Mol Sci       Date:  2020-10-26       Impact factor: 5.923

8.  Plasmodium infection inhibits tumor angiogenesis through effects on tumor-associated macrophages in a murine implanted hepatoma model.

Authors:  Benfan Wang; Qinyan Li; Jinyan Wang; Siting Zhao; Bayaer Nashun; Li Qin; Xiaoping Chen
Journal:  Cell Commun Signal       Date:  2020-09-24       Impact factor: 5.712

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.